Metoprolol Succinate Extended-Release Tablets Recalled for Storage Temperature Deviations
Cardinal Healthcare is recalling Metoprolol Succinate Extended-Release Tablets (50 mg) nationwide. Batch 2447J211 was exposed to temperatures outside labeled storage conditions, which could compromise medication effectiveness.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The FDA classified this as a Class II recall due to CGMP deviations from improper storage temperatures. Although no illnesses or injuries have been reported, temperature exposure of a cardiac medication creates a theoretical risk of reduced effectiveness. The score reflects this risk without confirmed adverse events.
Plain-English summary
Cardinal Healthcare is recalling Metoprolol Succinate Extended-Release Tablets, 50 mg (NDC 45963-676-96), distributed nationwide. The recalled batch is 2447J211.
The recall was initiated due to a Good Manufacturing Practice (CGMP) deviation. Products in the affected batch were exposed to temperatures outside the labeled storage conditions. This exposure may have compromised product quality and effectiveness.
Patients currently taking this medication should contact their healthcare provider or pharmacist regarding their specific situation and medication supply.
The recalled product
- Product
- METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)
- Brand
- METOPROLOL SUCCINATE
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 2447J211
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same brand · METOPROLOL SUCCINATE
- ModerateMetoprolol Succinate Extended-Release Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2026-05-20
- HighTeva metoprolol succinate 50 mg tablets failed dissolution specifications
FDA (Drugs) · 2026-03-11
- HighTeva metoprolol succinate 25 mg tablets failed dissolution specifications
FDA (Drugs) · 2026-03-11
- HighTeva metoprolol succinate 100 mg tablets failed dissolution specifications
FDA (Drugs) · 2026-03-11
- HighTeva metoprolol succinate 200 mg tablets failed dissolution specifications
FDA (Drugs) · 2026-03-11
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
Same hazard · improper storage
See all →- ModerateFairhope Cold Brew Coffee Concentrate Recall Over Missing Refrigeration Label
FDA (Food) · 2026-06-24
- ModerateOrtho Clinical Diagnostics Total Bili-Alkp XT Reagent Recall
FDA (Devices) · 2025-06-04
- ModerateHemoCue HemoTrol High Control Product Recalled Due to Storage Conditions
FDA (Devices) · 2025-06-04
- ModerateAbbott Rapid DX Multi Analyte Control Affected by Storage Temperature Excursion
FDA (Devices) · 2025-06-04
- ModerateAbbott Diagnostics HIV Combo Calibrator Affected by Cold Chain Exposure
FDA (Devices) · 2025-06-04